Living with Marfan syndrome II. Medication adherence and physical activity modification

Clinical Genetics

Volumn 60, Issue 4, 2001, Pages 283-292

  Peters, K F ^a,b   Horne, R ^c   Kong, F ^d   Francomano, C A ^e   Biesecker, B B ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF BRIGHTON   (United Kingdom)

^d WESTAT   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Beta blocker; Exercise; Health beliefs; Marfan syndrome; Medication

Indexed keywords

AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DILTIAZEM; LABETALOL; METOPROLOL; NADOLOL; PINDOLOL; PROPRANOLOL; VERAPAMIL;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; COPING BEHAVIOR; CORRELATION FUNCTION; DRUG USE; EXERCISE; FATIGUE; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MARFAN SYNDROME; PATIENT COMPLIANCE; PERCEPTION; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SYMPTOMATOLOGY;

ADULT; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; EXERCISE; FEMALE; GENETIC COUNSELING; HUMANS; LIFE STYLE; MALE; MARFAN SYNDROME; PATIENT COMPLIANCE; QUESTIONNAIRES; SELF MEDICATION; TREATMENT REFUSAL;

EID: 0034752348     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2001.600406.x     Document Type: Article

References (38)

1. Revised diagnostic criteria for the Marfan syndrome
2. Disorders of fibrillins and microfibrilogenesis: Marfan syndrome, MASS phenotype, contractural arachnodactyly and related conditions
3. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
4. The Marfan syndrome locus: Confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15q15-q21.3
5. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders
6. Therapeutic management of patients with Marfan syndrome: Focus on cardiovascular involvement
7. Operative management of Marfan syndrome: The Johns Hopkins experience
8. A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment
9. Beta-adrenergic blocking drugs
10. Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome
11. Survival and complication free survival in Marfan's syndrome: Implications of current guidelines
12. Life expectancy in the Marfan syndrome
13. Marfan syndrome in adolescents and young adults: Psychosocial functioning and knowledge
14. Psychosocial adaptation in adolescents and young adults with Marfan syndrome: An exploratory study
15. Representations of medication and treatment: Advances in theory and measurement
16. Patients' beliefs about treatment: The hidden determinant of treatment outcome?
17. Illness representations: Theoretical foundations
18. From intentions to actions: A theory of planned behavior
19. Patient's ideas about medicines: A qualitative study in a general practice population
20. Reflections on Medicines and Medications: A Qualitative Analysis Among People on Long-term Drug Treatments
21. The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication
22. Perspective of the patient with rheumatoid arthritis on issues related to missed medication
23. Managing hypertention: Beliefs and responses to medication among cultural groups
24. The meaning of medications: Another look at compliance
25. Living with Marfan syndrome I: Perceptions of the condition
26. The Illness Perception Questionnaire: A new method for assessing the cognitive representation of illness
27. Illness representations and coping with health threats
28. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness
29. Recall of recommendations and adherence to advice among patients with chronic medical conditions
30. Self-regulation, health and behavior: A perceptual-cognitive approach
31. The 'New Luddites'
32. One to be taken as directed: Reflections on non-adherence (non-compliance)
33. Genetic counseling for pregnant adolescents
34. The measurement of compliance: Medication taking